New Age Ventures

New Age Ventures is an early-stage venture firm with a website and LinkedIn presence consistent with a small or emerging US manager, with limited published thesis or check-size data. Without disclosure, the most honest read is a generalist seed-stage investor with selective healthcare exposure rather than a dedicated healthcare fund. Healthcare exposure is plausibly opportunistic and most likely to appear in digital health, behavioral health, and AI-native health categories where the company is fundamentally a software business with strong scaling potential. AI focus is plausibly real and applied. Without disclosed stage or check data, anchor expectations to typical seed norms: pre-seed and seed checks in the USD 100K to USD 750K range, often co-investing rather than leading. This is the wrong door for capital-intensive therapeutics, devices, or hospital enterprise software where deep healthcare expertise is the unlock. It is a plausible co-investor for early healthcare software founders who already have a credible lead and want additional capital from a generalist seed manager. Entry path is the website contact and direct LinkedIn outreach to the principals; warm introductions through shared seed networks materially raise reply rates. Founders should be specific about syndicate fit and avoid generic decks. Without disclosure, treat the firm as a possible filler check rather than a primary fundraising target until a relationship pathway emerges.